These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 7799449)

  • 1. Hypothesis: apoptosis may be a mechanism for the transition to heart failure with chronic pressure overload.
    Bing OH
    J Mol Cell Cardiol; 1994 Aug; 26(8):943-8. PubMed ID: 7799449
    [No Abstract]   [Full Text] [Related]  

  • 2. [The role of myocardial apoptosis in the development of heart failure].
    Andréka P; Müzes G; Nádházi Z
    Orv Hetil; 1999 Jan; 140(3):135-42. PubMed ID: 9990818
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [From myocardial hypertrophy to heart failure: role of the interstitium].
    Barsotti A; Dini FL; Nardini V; Di Muzio M; Gallina S; Di Napoli P; Calafiore AM; Trevi G
    Cardiologia; 1993 Dec; 38(12 Suppl 1):67-77. PubMed ID: 8020050
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Functionalmorphology of acute heart insufficiency].
    Hort W
    Verh Dtsch Ges Pathol; 1967; 51():114-24. PubMed ID: 4174674
    [No Abstract]   [Full Text] [Related]  

  • 5. Transition from hypertrophy to failure.
    Lorell BH
    Circulation; 1997 Dec; 96(11):3824-7. PubMed ID: 9403601
    [No Abstract]   [Full Text] [Related]  

  • 6. EUK-8, a superoxide dismutase and catalase mimetic, reduces cardiac oxidative stress and ameliorates pressure overload-induced heart failure in the harlequin mouse mutant.
    van Empel VP; Bertrand AT; van Oort RJ; van der Nagel R; Engelen M; van Rijen HV; Doevendans PA; Crijns HJ; Ackerman SL; Sluiter W; De Windt LJ
    J Am Coll Cardiol; 2006 Aug; 48(4):824-32. PubMed ID: 16904556
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Myocyte death and growth in the failing heart.
    Anversa P; Leri A; Beltrami CA; Guerra S; Kajstura J
    Lab Invest; 1998 Jul; 78(7):767-86. PubMed ID: 9690556
    [No Abstract]   [Full Text] [Related]  

  • 8. [Morphology of the acute and chronic heart dilatation and cardiac insufficiency].
    Hort W
    Verh Dtsch Ges Kreislaufforsch; 1968; 34():1-15. PubMed ID: 4242130
    [No Abstract]   [Full Text] [Related]  

  • 9. The role of Fas in the progression of ischemic heart failure: prohypertrophy or proapoptosis.
    Feng QZ; Zhao YS; Abdelwahid E
    Coron Artery Dis; 2008 Nov; 19(7):527-34. PubMed ID: 18923250
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Upregulation of heat shock transcription factor 1 plays a critical role in adaptive cardiac hypertrophy.
    Sakamoto M; Minamino T; Toko H; Kayama Y; Zou Y; Sano M; Takaki E; Aoyagi T; Tojo K; Tajima N; Nakai A; Aburatani H; Komuro I
    Circ Res; 2006 Dec; 99(12):1411-8. PubMed ID: 17095722
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of cardiac remodeling by pravastatin is associated with amelioration of endoplasmic reticulum stress.
    Zhao H; Liao Y; Minamino T; Asano Y; Asakura M; Kim J; Asanuma H; Takashima S; Hori M; Kitakaze M
    Hypertens Res; 2008 Oct; 31(10):1977-87. PubMed ID: 19015605
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Programmed cell death in the progression of heart failure.
    Sabbah HN; Sharov VG; Goldstein S
    Ann Med; 1998 Aug; 30 Suppl 1():33-8. PubMed ID: 9800881
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Myocardial hypertrophy and heart failure: a complex relationship].
    Barsotti A; Dini FL
    Cardiologia; 1993 Mar; 38(3):191-205. PubMed ID: 8339309
    [No Abstract]   [Full Text] [Related]  

  • 14. Resident cardiac mast cells: are they the major culprit in the pathogenesis of cardiac hypertrophy?
    Balakumar P; Singh AP; Ganti SS; Krishan P; Ramasamy S; Singh M
    Basic Clin Pharmacol Toxicol; 2008 Jan; 102(1):5-9. PubMed ID: 17973902
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Molecular biology of heart failure].
    Eng-Ceceña L
    Arch Cardiol Mex; 2007; 77 Suppl 4():S4-94-105. PubMed ID: 18938705
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Myocyte loss in chronic heart failure.
    Rayment NB; Haven AJ; Madden B; Murday A; Trickey R; Shipley M; Davies MJ; Katz DR
    J Pathol; 1999 Jun; 188(2):213-9. PubMed ID: 10398167
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor necrosis factor-alpha mediates cardiac remodeling and ventricular dysfunction after pressure overload state.
    Sun M; Chen M; Dawood F; Zurawska U; Li JY; Parker T; Kassiri Z; Kirshenbaum LA; Arnold M; Khokha R; Liu PP
    Circulation; 2007 Mar; 115(11):1398-407. PubMed ID: 17353445
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overt expression of AP-1 reduces alpha myosin heavy chain expression and contributes to heart failure from chronic volume overload.
    Freire G; Ocampo C; Ilbawi N; Griffin AJ; Gupta M
    J Mol Cell Cardiol; 2007 Oct; 43(4):465-78. PubMed ID: 17720185
    [TBL] [Abstract][Full Text] [Related]  

  • 19. S100 proteins: a missing piece in the puzzle of heart failure?
    Pleger ST; Most P; Katus HA
    Cardiovasc Res; 2007 Jul; 75(1):1-2. PubMed ID: 17531210
    [No Abstract]   [Full Text] [Related]  

  • 20. Myocyte death in heart failure.
    Anversa P; Kajstura J; Olivetti G
    Curr Opin Cardiol; 1996 May; 11(3):245-51. PubMed ID: 8835866
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.